13 insiders reported 60 Form 4 transactions for Adverum Biotechnologies, Inc. (ADVM) over the past 18 months (most recent 2025-12-10). Recent activity: Machado Patrick (Director) Sell 8,818 shares, Rubinstein Linda M (CHIEF FINANCIAL OFFICER) Buy 48,750 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 8,125 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Buy 85,000 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 88,332 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-10 | Machado Patrick | Director | Sell | 8,818 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 48,750 | $204,750 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Buy | 85,000 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 88,332 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 8,125 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Buy | 85,000 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 54,874 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 80,189 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 13,125 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Buy | 150,000 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 157,333 | $0 |
| 2025-12-10 | Svoronos Dawn | Director | Sell | 5,000 | $0 |
| 2025-12-10 | Lupher, Jr. Mark L. | Director | Sell | 13,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 150,000 | $630,000 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 351,513 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 25,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 500,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 522,666 | $0 |
| 2025-12-10 | Scopa James Paul | Director | Sell | 10,333 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 61,150 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 42,000 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 42,000 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 85,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-10
